Aprea Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Aprea Therapeutics, Inc. (APRE) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -1.20% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-16
- Aprea Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -1.20%.
- Aprea Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.20%.
- Aprea Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.70%.
- Aprea Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -2.70%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -1.20% 10-K · filed 2026-03-16 | |
| 2023-12-31 | -0.20% 10-K · filed 2025-03-25 | |
| 2022-12-31 | -0.70% 10-K · filed 2024-03-26 | |
| 2021-12-31 | -2.70% 10-K · filed 2024-03-26 | 2.70% 10-K · filed 2022-03-15 |
| 2020-12-31 | -0.40% 10-K · filed 2023-03-30 | 0.40% 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |